Request Form - CENTOGENE
Request Form - CENTOGENE
Request Form - CENTOGENE
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Chief Medical Director:<br />
Technical supervision:<br />
Medical counseling:<br />
Prof. Arndt Rolfs, MD<br />
Dr. Adolf Mühl<br />
Dr. Margareta Holub, MD<br />
Centogene AG<br />
Place of Business Rostock<br />
Schillingallee 68<br />
18057 Rostock<br />
Germany<br />
Tel.: +49 (0)381 20365 10<br />
Fax: +49 (0)381 203652 19<br />
Mail: office@centogene.com<br />
Web: www.centogene.com<br />
Biochemical Requisition <strong>Form</strong> Rev. 14<br />
Please fill out all the red-marked/italicized fields with special care.<br />
Patient Data (or sticker)<br />
Physician Data (hospital/clinic stamp)<br />
Last Name: ....................................... Physician’s Name: .....................................<br />
First Name: ....................................... Hospital/Dep: ..........................................<br />
Mailing address: .................................. Mailing address: .......................................<br />
Zip-code/City: .................................... Zip-code/City: .........................................<br />
Date of birth: ........................ (dd/mm/yyyy) Phone: ...................................................<br />
Sex: ❏m ❏w Fax: ......................................................<br />
E-Mail: ...................................................<br />
Date of sampling: ...............................<br />
Time of sampling: ............................... Submit copy of report by e-mail: ❏yes ❏no<br />
Name of sample taker........................... Invoice to: ❏Patient ❏Clinic/Hospital<br />
Sample type:<br />
If invoice will be paid by patient directly, we need the<br />
signature of the patient or his/her parents<br />
Signature of the patient or parents ………………………...<br />
❏E – EDTA blood ❏S – Serum ❏P – Plasma ❏L – CSF ❏U – Urine ❏D – Dried blood spot<br />
Clinical Symptoms:<br />
Diagnosis:<br />
To be filled in by physician please<br />
(A detailed medical history is an important prerequisite to an adequate analysis)<br />
Hypoglycaemia: ❏yes ❏no Metabolic acidosis: ❏yes ❏no<br />
Hyperammonaemia: ❏yes ❏no Muscular hypotonia: ❏yes ❏no<br />
Epilepsy: ❏yes ❏no Psychomotor retardation: ❏yes ❏no<br />
Hepatopathy: ❏yes ❏no CK-increase: ❏yes ❏no<br />
Medication: ❏yes ❏no Infusion: ❏yes ❏no<br />
(Please list) ......................................................... (Please list) ..................................................<br />
Special diet: ❏yes ❏no Positive family history: ❏yes ❏no<br />
(Please list) ........................................................ (Pedigree data to be attached in separate document)<br />
<strong>Request</strong>ing Physician:<br />
Date / signature: ……………………………..<br />
Contact:<br />
Technical supervision: A. Mühl, PhD adolf.muehl@centogene.com<br />
Medical consultant: M. Holub, MD margareta.holub@centogene.com page 1 of 2
<strong>Request</strong> (for molecular genetics please download the request form from www.centogene.com)<br />
1. Basic-metabolic diagnostics:<br />
Address for dispatch of samples:<br />
Centogene AG<br />
Place of Business Rostock<br />
Schillingallee 68<br />
18057 Rostock<br />
Germany<br />
❏ Analysis of organic acids/urine 4 , acylcarnitines/dried blood 6 , amino acids/plasma 2 , MPS/urine 4<br />
2. Amino acid metabolism<br />
Amino acids: ❏(E) 2 ; ❏(D) 6 ; ❏(U) 4 ; ❏(L) 1 ❏Homocysteine (P, E; cooled) 3 ❏Phenylalanine (D) 6<br />
3. Fatty acid metabolism<br />
❏Acylcarnitines (preferably D but also E) 6,2<br />
4. Special tests URINE<br />
❏Guanidinoacetate (U) 4 ❏Pipecolic acid (U) 4 ❏Creatine / Creatinine (U) 4 ❏Mucopolysaccharides (U) 4<br />
❏Succinylacetone (U) 4 ❏Oligosaccharides (U) 5 ❏Orotic acid (U) 4 ❏Organic acids (U) 4<br />
5. Special tests BLOOD<br />
❏ Pipecolic acid (E) 2 ❏ Total galactose (D) 6 ❏ Guanidinoacetate (D or E) 6,2 ❏ Succinylacetone (D) 6<br />
6. Lysosomal enzymes<br />
❏ Screening of lysosomal storage disorders: Fabry, Gaucher, Krabbe, Niemann-Pick A/B, Pompe, Hurler (MPS-I) disease 7<br />
❏α-Fucosidase (E, S) 2,1 ❏MLD; Arylsulfatase A (E) 4<br />
❏α-Mannosidase (E, S) 2,1 ❏MPS-I; α-Iduronidase (D, E) 6,2<br />
❏GM1-Gangliosidosis/MPS IVB; β-Galactosidase (E) 2 ❏MPS-II; α-Iduronatsulfatase (D, E) 6,2<br />
❏MPS VII; β-Glucuronidase (E, S) 2,1 ❏MPS-III a-d (E) 3<br />
❏Fabry; α-Galactosidase (D, E) 6,2 ❏Pompe; α-Glucosidase (D, E) 6,2<br />
❏Gaucher; β-Glucosidase (D, E) 6,2 ❏Niemann-Pick A/B; Sphingomyelinase (D, E) 6,2<br />
❏GM2-Gangliosidosis; total hexosaminidase (E) 2 ❏GM2-Gangliosidosis; Hexosaminidase A (E) 2<br />
❏Krabbe; β-Galactocerebrosidase (D, E) 6<br />
7. Sterol metabolism<br />
❏17OH-Progesterone (D) 6 ❏Dehydrocholesterole (Smith-Lemli-Opitz syndrome) (E) 2<br />
8. Biomarker<br />
❏Fabry disease (lyso-Gb3) (D, E, P, S)<br />
❏Gaucher disease (lyso-Gb1) (D, E, P, S)<br />
❏Niemann-Pick A/B/C (Sphingosylphosphorylcholine + derivate 509) (D, E, P, S)<br />
9. Other enzymes<br />
❏Biotinidase (D) 6 ❏Galactose-1P-uridyltransferase (D) 6<br />
10. Newborn-Screening<br />
❏Newborn-Screening (D) 7 (please call for additional information: +43 (0) 1 798 50 06 300)<br />
Minimal amount of sample material per analysis: (see numbers after each analysis)<br />
1) 0, 5 ml 4 ) 5 ml 7) 3 Circles<br />
2) 1 ml 5) 10 ml<br />
3) 2 ml 6) 1 Circle<br />
Contact:<br />
Technical supervision: A. Mühl, PhD adolf.muehl@centogene.com<br />
Medical consultant: M. Holub, MD margareta.holub@centogene.com page 2 of 2